Literature DB >> 8255459

MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration?

J Kulisevsky1, J Pujol, C Junqué, J Deus, J Balanzó, A Capdevila.   

Abstract

In cirrhotic patients, even in a stable nonencephalopathic state, MRI may show cerebral atrophy and increased signal in globus pallidus on T1-weighted sequences. We investigated the relationship between cerebral atrophy and increased pallidal signal and the clinical status of 30 cirrhotic patients. We found a weak association between the two MRI findings. There were different patterns of clinical variables related to the imaging findings. Performance on motor tasks involving speed correlated with the pallidal signal and plasma ammonia levels but not with atrophy. Test results for memory and frontal-premotor function were associated with brain atrophy but not with the pallidal signal or with ammonia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255459     DOI: 10.1212/wnl.43.12.2570

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 2.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 3.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

4.  Ammonia and manganese increase arginine uptake in cultured astrocytes.

Authors:  A S Hazell; M D Norenberg
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

5.  In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.

Authors:  A Cagnin; S D Taylor-Robinson; D M Forton; R B Banati
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

6.  MR brain imaging of fucosidosis type I.

Authors:  P Galluzzi; A Rufa; P Balestri; A Cerase; A Federico
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure.

Authors:  Susana Rivera-Mancía; Sergio Montes; Maricela Méndez-Armenta; Pablo Muriel; Camilo Ríos
Journal:  Metab Brain Dis       Date:  2009-04-08       Impact factor: 3.584

8.  Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation.

Authors:  K Weissenborn; C Ehrenheim; A Hori; S Kubicka; M P Manns
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

9.  Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension.

Authors:  Kshaunish Das; Paramjeet Singh; Yogesh Chawla; Ajay Duseja; Radha Krishan Dhiman; Sudha Suri
Journal:  Dig Dis Sci       Date:  2008-08-08       Impact factor: 3.199

10.  Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.